Latest Regulatory News

Argenica Therapeutics reports encouraging functional improvements in stroke patients treated with ARG-007, setting the stage for a targeted Phase 2b trial focused on patient-centered outcomes.

Johns Lyng Group shares will halt trading following Supreme Court approval of its acquisition by Sherwood BidCo, controlled by Pacific Equity Partners.

Highfield Resources has locked in A$10 million through convertible notes from existing investors to tackle a key permit issue and push forward its flagship Muga Potash Project in Spain.

Cobalt Blue Holdings attributes its recent share price jump to a surge in cobalt prices driven by new export controls in the Democratic Republic of Congo, while confirming no undisclosed company information is influencing trading.

Halo Technologies Holdings has responded to ASX queries about a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with continuous disclosure rules.

The Federal Court of Australia has approved the acquisition of NSX Limited by a related entity of the Canadian Securities Exchange operator, setting the stage for NSX’s delisting from the ASX later this month.

Elevate Uranium Ltd has agreed to sell its Oobagooma Uranium Project to Orpheus Uranium Ltd in a deal combining cash and milestone-based equity payments, aligning with Elevate’s pivot towards its innovative U-pgrade beneficiation technology and other core assets.

Orpheus Uranium Limited has agreed to acquire the Oobagooma Uranium Project in Western Australia, unlocking significant historical uranium mineralisation and exploration potential in the Canning Basin.

Falcon Metals confirms exceptional high-grade gold intercepts at its Blue Moon project, extending the renowned Bendigo Goldfield. The company accelerates exploration with new drill pads and a second rig, backed by a strong cash position.

Aguia Resources has locked in a R$6 million (A$1.7 million) bank loan to advance its Tres Estradas phosphate mine in Brazil, aiming for over 160,000 tonnes annual production by 2027. Initial sales agreements and a strong market backdrop set the stage for a potentially lucrative operation.

Chariot Corporation confirms extensive lithium-bearing pegmatites at its Nigerian Fonlo and Iganna projects, setting the stage for small-scale mechanized mining and systematic exploration in 2026. Assay results and acquisition completion remain key near-term milestones.

Clarity Pharmaceuticals’ Co-PSMA Phase II trial shows its Cu-SAR-bisPSMA diagnostic agent detects more prostate cancer lesions than current standard imaging, promising earlier and more accurate recurrence detection.